News

אוזמפיק, שאושרה ב-2017 כתרופה לסוכרת, החלה לצבור יחסי ציבור כתרופה אשר מועילה גם נגד השמנה בתחילת שנות ה-2020. נובו הגישה את ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in individuals aged 12 ...
After 72 weeks of treatment, people taking Zepbound lost about 50 pounds, compared with 33 pounds for those taking Wegovy. The weight loss drug Zepbound (tirzepatide) led to 50 percent more weight ...
מחקר ישראלי חדש מסורוקה מצא כי זריקות מהדור החדש לטיפול בסוכרת והשמנת יתר עשויות לשפר את מצבם של חולות הסובלות מלחץ ...
Share on Pinterest A Wegovy weight loss pill from Novo Nordisk is forthcoming, providing an alternative to injectable GLP-1 drugs. Mads Claus Rasmussen/Ritzau Scanpix/AFP via Getty Images Federal ...
Shares of Septerna Inc. were soaring in Wednesday trading after the biotech clinched a partnership with Wegovy and Ozempic parent Novo Nordisk to collaborate on oral obesity and Type 2 diabetes ...
People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications.
They found dark chocolate biscuits triggered the key fullness hormone GLP-1, which is the target of appetite-suppressing injections like Wegovy and Mounjaro. People reported feeling more full ...
A leading expert has sounded a warning bell for users of Ozempic, Mounjaro and Wegovy to be aware the popular drugs can set off the agonising shingles virus. Chairwoman of the peak body for GPs ...